MedTrace Logo

Autologous Cellular Graft in Surgical Treatment of Vitiligo

NCT05503368 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-01-25

No results posted yet for this study

Summary

This is a double blinded self controlled randomized trial to assess Autologous Micro Cellular Grafts in surgical treatment of stable resistant vitiligo. Given the stem cells, progenitor cells, and growth factors rich hair follicle based suspension resulting from Autologous Cellular Micro grafts (ACM), we aim at assessing the efficacy of ACM generated suspension in comparison to follicle cell suspension in surgical treatment of stable resistant vitiligo.

Conditions

  • Vitiligo, Generalized

Interventions

PROCEDURE

surgical treatment of vitiligo using NCES

NCES is the standard technique for surgical treatment of vitiligo, herein we compare the standard technique, to added autologous cellular micro-grafts and to follicle cell suspension

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Rania M Mogawer · Kasr Alainy, Cairo University Hospitals

  • Samia M Esmat · Kasr Alainy, Cairo University Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2023-11-30
Completion
2024-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05503368 on ClinicalTrials.gov